한 눈에 보는 포지셔닝
- 모멘텀 약함
$2.86
▼ $2.51-46.74%
거래량
15.06M
애프터마켓 마감$2.91+$0.05(+1.75%)· 08:59 KST 기준
Healthcare 섹터
최근 90일 변동 없음
FY2026 Q1·
Operator: 안녕하십니까. 오늘 회의에 참석해 주셔서 감사합니다. Myriad Genetics 2026년 1분기 실적 발표 컨퍼런스 콜에 오신 것을 환영합니다. [Operator Instructions] 오늘 …
트랜스크립트 보기 →FY2025 Q4·
Operator: 안녕하십니까, 오늘 회의에 참석해 주셔서 감사합니다. Myriad Genetics 2025년 4분기 및 연간 실적 발표 컨퍼런스 콜에 오신 것을 환영합니다. [운영자 지침] 오늘 컨퍼런스는 녹음되고…
트랜스크립트 보기 →2026 Q2
재무 한 눈에· FY 기준 · YoY 비교
$824.50M
-1.6% YoY
vs 전년 $837.60M
-8.2%
+6.5p YoY
-99.4%
-3.1%
+1.5p YoY
FCF $-25.60M
57.0%
낮을수록 좋음
-1.6x
손익·재무상태·현금흐름을 연/분기 토글로 5년 추이까지
| 항목 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| 매출 (Revenue) | $771.40M | $772.60M | $851.10M | $638.60M | $557.00M | $690.60M | $678.40M | $753.20M | $837.60M | $824.50M |
| 매출원가 | $171.20M | $177.20M | $201.00M | $186.10M | $178.20M | $197.60M | $202.00M | $236.20M | $252.20M | $247.90M |
| 매출총이익 (Gross Profit) | $600.20M | $595.40M | $650.10M | $452.50M | $378.80M | $493.00M | $476.40M | $517.00M | $585.40M | $576.60M |
| 매출총이익률 | 77.8% | 77.1% | 76.4% | 70.9% | 68.0% | 71.4% | 70.2% | 68.6% | 69.9% | 69.9% |
| 영업이익 (Operating Income) | $49.40M | $118.70M | $7.60M | -$231.70M | -$194.80M | -$190.50M | -$140.60M | -$257.40M | -$123.50M | -$67.80M |
| 영업이익률 | 6.4% | 15.4% | 0.9% | -36.3% | -35.0% | -27.6% | -20.7% | -34.2% | -14.7% | -8.2% |
| 당기순이익 (Net Income) | $21.80M | $131.00M | $4.60M | -$199.50M | -$223.70M | -$27.20M | -$112.00M | -$263.30M | -$127.30M | -$365.90M |
| 순이익률 | 2.8% | 17.0% | 0.5% | -31.2% | -40.2% | -3.9% | -16.5% | -35.0% | -15.2% | -44.4% |
| EPS (희석) | $0.32 | $1.82 | $0.06 | $-2.69 | $-2.99 | $-0.35 | $-1.39 | $-3.18 | $-1.41 | $-3.96 |
| EBITDA | $96.40M | $113.30M | $85.00M | -$140.50M | -$123.40M | $12.30M | -$84.70M | -$197.40M | -$59.50M | -$330.90M |
| 잉여현금흐름 (FCF) | $100.10M | $107.50M | $75.10M | $50.50M | -$40.10M | $600.0K | -$151.60M | -$68.20M | $700.0K | $4.60M |
5년 평균 GPM
70.0%
5년 평균 OPM
-21.1%
5년 평균 NPM
-23.0%
5년 평균 ROE
-33.3%
5년 평균 ROIC
-13.8%
최근 8분기 EPS 평균 서프라이즈 -53.2%
| 항목 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| 현금 · 단기투자 | $150.70M | $180.60M | $136.90M | $136.90M | $150.70M | $339.80M | $114.90M | $140.90M | $102.40M | $149.60M |
| 유동자산 합계 | $317.10M | $326.40M | $348.60M | $348.60M | $389.40M | $484.80M | $274.60M | $313.60M | $298.00M | $332.60M |
| 자산 총계 | $1.22B | $1.17B | $1.56B | $1.56B | $1.42B | $1.32B | $1.20B | $1.15B | $1.03B | $706.60M |
| 부채 총계 | $446.60M | $209.20M | $473.80M | $473.80M | $537.80M | $352.90M | $312.90M | $363.30M | $326.50M | $338.60M |
| 자본 총계 | $778.20M | $964.90M | $1.09B | $1.09B | $881.00M | $967.80M | $885.80M | $783.20M | $701.10M | $368.00M |
부채비율 (D/E)
92.0%
유동비율
249%
순현금
-$53.30M
자본 5년 CAGR
-21.5%
| 항목 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| 영업활동 현금흐름 | $106.20M | $115.90M | $83.70M | $60.70M | -$26.90M | $18.60M | -$106.30M | -$110.90M | -$8.70M | $1.80M |
| 당기순이익 | $17.40M | $133.30M | $4.60M | -$199.50M | -$223.70M | -$27.20M | -$112.00M | -$263.30M | -$127.30M | -$365.90M |
| 감가상각비 | $48.30M | $54.40M | $73.00M | $72.00M | $71.40M | $62.80M | $52.70M | $61.90M | $61.20M | $53.70M |
| 주식보상비용 (SBC) | $29.90M | $27.10M | $33.50M | $25.20M | $24.30M | $36.30M | $38.10M | $40.70M | $49.80M | $35.20M |
| 운전자본 변동 | $5.60M | $8.50M | -$39.40M | $117.90M | $30.20M | $120.80M | -$83.50M | $27.00M | -$54.40M | -$19.30M |
| 기타 영업 조정 | $3.00M | -$83.60M | -$1.10M | $99.20M | $70.90M | -$139.40M | $30.30M | $23.40M | $62.30M | $330.50M |
| 투자활동 현금흐름 | -$146.30M | -$11.60M | -$286.40M | $19.30M | $61.60M | $274.40M | -$77.50M | $31.90M | -$11.90M | -$27.40M |
| CapEx (자본적 지출) | -$6.10M | -$8.40M | -$8.60M | -$10.20M | -$13.20M | -$18.00M | -$45.30M | -$73.30M | -$29.70M | -$27.40M |
| 재무활동 현금흐름 | $71.80M | -$95.00M | $182.30M | -$10.00M | -$1.00M | -$150.60M | -$8.00M | $152.90M | -$7.40M | $64.20M |
| 자사주 매입 | -$31.60M | $0 | -$50.00M | $0 | -$3.90M | $0 | $0 | $0 | $0 | $0 |
| 배당금 지급 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| 잉여현금흐름 (FCF) | $100.10M | $107.50M | $75.10M | $50.50M | -$40.10M | $600.0K | -$151.60M | -$184.20M | -$38.40M | -$25.60M |
FCF 마진
-3.1%
CapEx / 매출
3.3%
주주환원 비중
0%
FCF 5년 CAGR
NaN%
동종업계 6개와 비교한 상대적 위치. 정규화·마진·산점도·박스플롯으로
$65.18B
매출 · YoY +44.7%
$94.19B
매출 · YoY +6.0%
$61.16B
매출 · YoY +8.6%
$447.57B
매출 · YoY +11.8%
$64.93B
매출 · YoY +1.2%
$54.81B
매출 · YoY +6.0%
$44.56B
매출 · YoY +3.9%
$309.06B
매출 · YoY +6.4%
12M 수익률: MRK +60.0% · LLY +56.8% · JNJ +44.7% · UNH +37.3% · NVS +23.4% · ABBV +22.9% · TMO +16.9% · NVO -16.6% · MYGN -55.1%
색상은 섹터 내 상대 위치 (초록=좋음 → 빨강=나쁨)
| 티커 | 매출 (FY) | 매출 YoY | 영업이익률 | ROE | PER | EV/EBITDA | FCF 수익률 |
|---|---|---|---|---|---|---|---|
| LLY | $65.18B | +44.7% | 45.6% | 77.8% | 46.7 | 35.8x | 0.9% |
| JNJ | $94.19B | +6.0% | 27.2% | 32.9% | 18.8 | 13.0x | 3.9% |
| ABBV | $61.16B | +8.6% | 32.8% | -129.2% | 96.4 | 26.7x | 4.4% |
| UNH | $447.57B | +11.8% | 4.2% | 12.8% | 25.0 | 15.4x | 5.4% |
| MRK | $64.93B | +1.2% | 36.2% | 34.7% | 14.4 | 10.6x | 4.7% |
| NVS | $54.81B | +6.0% | 31.2% | 30.5% | 19.0 | 12.7x | 6.6% |
| TMO | $44.56B | +3.9% | 18.2% | 12.6% | 32.6 | 21.7x | 2.9% |
| NVO | $309.06B | +6.4% | 41.3% | 52.8% | 14.0 | 9.8x | 2.0% |
X: 매출 YoY · Y: PER · 원 크기: 매출 규모
분할선은 표시 피어들의 중앙값(median).